Status:
ENROLLING_BY_INVITATION
Parent and Infant Inter(X)Action Intervention (PIXI)
Lead Sponsor:
RTI International
Collaborating Sponsors:
University of North Carolina, Chapel Hill
Conditions:
Fragile X Syndrome
Angelman Syndrome
Eligibility:
All Genders
Up to 99 years
Phase:
NA
Brief Summary
The objective is to develop and test, through an iterative process, an intervention to address and support the development of infants with a confirmed diagnosis of a neurogenetic disorder with associa...
Detailed Description
The primary goal of the proposed project is to develop and test, through an iterative process, an intervention to address and support the development of infants with a rare neurogenetic condition (e.g...
Eligibility Criteria
Inclusion
- Infants 15 months of age or younger who have received a diagnosis which was not sought solely due to parental concerns about the infant (e.g. diagnosis due to prenatal or newborn screening, cascade testing following diagnosis of a family member).
- English must be the primary language spoken in the home because all assessment measures and intervention protocol are in English.
Exclusion
- \- Infants may not be blind or have a severe hearing impairment as the intervention and assessments are not appropriate for these children.
Key Trial Info
Start Date :
November 30 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03836300
Start Date
November 30 2018
End Date
December 31 2026
Last Update
July 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
RTI International
Research Triangle Park, North Carolina, United States, 27709